Ono Venture Investment (investor - Corporate Investor)
See something wrong or missing? Let us know
Offices:San Francisco
Ono Venture Investment - OVI is the corporate venture capital arm of Ono Pharmaceutical Co in the USA
Average round investment:32M USD
Average number per year:1.0
Distribution:
2025 (1)
Portfolio companies:
Alchemab
Alchemab
Mostly invests in:
United Kingdom (1)
Biotech (1)
United Kingdom (1)
Biotech (1)
1 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.

Belgium
Netherlands
Austria
Germany
Switzerland
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Ireland
Italy
Portugal
Spain